Novel quinazoline-2,4-dione derivative and pharmaceutical composition for prevention and treatment of cranial nervous system diseases containing the same
The present invention relates to a novel quinazoline-2,4-dione derivative of formula (I), a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a compound of formula (I) as an active ingredient for preventing or treating neurological brain disease.